Exane Derivatives’s UBS Group UBS Stock Holding History

Exane Derivatives’s Portfolio UBS Stock Details UBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,993	Closed	-$5.15M	–	1011
2021 Q3	$5.15M	Buy	11,993 +814	+7%	+$13.2K	1.24%	9
2021 Q2	$4.34M	Sell	11,179 -2,713	-20%	-$42.8K	0.99%	16
2021 Q1	$5.55M	Buy	13,892 +7,019	+102%	+$108K	1.59%	7
2020 Q4	$1.52M	Sell	6,873 -25,015	-78%	-$331K	0.45%	42
2020 Q3	$2.37M	Buy	31,888 +10,269	+47%	+$123K	0.69%	33
2020 Q2	$1.62M	Sell	21,619 -16,519	-43%	-$170K	0.43%	72
2020 Q1	$893K	Buy	38,138 +14,959	+65%	+$172K	0.25%	86
2019 Q4	$710K	Sell	23,179 -18,797	-45%	-$224K	0.13%	124
2019 Q3	$582K	Sell	41,976 -39	-0.1%	-$439	0.1%	151
2019 Q2	$722K	Sell	42,015 -2,336	-5%	-$28.6K	0.13%	135
2019 Q1	$1.07M	Buy	44,351 +11,027	+33%	+$140K	0.21%	107
2018 Q4	$16M	Sell	33,324 -6,157	-16%	-$83.5K	2.87%	4
2018 Q3	$2.55M	Buy	39,481 +5,764	+17%	+$90.6K	0.48%	66
2018 Q2	$14.1M	Buy	33,717 +3,006	+10%	+$48.9K	2.35%	8
2018 Q1	$2.82M	Buy	30,711 +11,383	+59%	+$216K	0.56%	36
2017 Q4	$4.81M	Buy	19,328 +1,064	+6%	+$18.5K	0.83%	18
2017 Q3	$6.99M	Sell	18,264 -2,114	-10%	-$36.2K	1.31%	12
2017 Q2	$5.34M	Sell	20,378 -21,654	-52%	-$352K	1.15%	15
2017 Q1	$5.09M	Buy	42,032 +7,929	+23%	+$128K	1.15%	19
2016 Q4	$5.49M	Buy	34,103 +3,500	+11%	+$52.7K	1.08%	13
2016 Q3	$1.93M	Buy	+30,603	New	+$417K	0.29%	65
2016 Q2	–	Sell	-36,009	Closed	-$2.99M	–	625
2016 Q1	$2.99M	Buy	36,009 +6,121	+20%	+$99.4K	0.4%	50
2015 Q4	$6.86M	Buy	29,888 +3,935	+15%	+$76.8K	0.94%	36
2015 Q3	$5.25M	Buy	25,953 +8,349	+47%	+$177K	0.66%	42
2015 Q2	$4.4M	Sell	17,604 -387	-2%	-$8.08K	0.47%	46
2015 Q1	$3.09M	Buy	17,991 +5,136	+40%	+$89.4K	0.34%	53
2014 Q4	$1.88M	Buy	+12,855	New	+$220K	0.26%	70

Other funds holding UBS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Exane Derivatives's UBS Position: Q2 2022 in Review

Exane Derivatives reduced its UBS Group (UBS) stake by 49% in Q2 2022, selling an estimated $384K and leaving 22,455 shares worth $360K. The position accounts for 0.21% of the portfolio, ranked #118.

Exane Derivatives first reported a position in UBS in Q4 2014 and has held it in 25 quarters since. The position peaked at $68.1M in Q3 2017. 368 funds tracked by Wall St. Rank hold UBS as of Q2 2022.

Exane Derivatives held 22,455 shares of UBS Group worth $360K as of Q2 2022.
Exane Derivatives sold 21,925 UBS Group shares in Q2 2022, an estimated $384K.
UBS Group made up 0.21% of Exane Derivatives's portfolio in Q2 2022, its #118 holding.
Exane Derivatives first reported a position in UBS Group in Q4 2014 and has held it in 25 quarters since.
Exane Derivatives's UBS Group position peaked at $68.1M in Q3 2017.
368 funds tracked by Wall St. Rank held UBS Group as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.